ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+21.09%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$146M
AUM Growth
+$146M
(+13%)
Cap. Flow
+$8.7M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
34.57%
Holding
87
New
21
Increased
17
Reduced
19
Closed
26
Top Buys
| 1 |
Martin Marietta Materials
MLM
|
$3.92M |
| 2 |
Icon
ICLR
|
$3.56M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$3.38M |
| 4 |
Edwards Lifesciences
EW
|
$3.28M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$3.11M |
Top Sells
| 1 |
AbbVie
ABBV
|
$3.76M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$2.72M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$2.4M |
| 4 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$2.4M |
| 5 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$2.39M |
Sector Composition
| 1 | Healthcare | 41.45% |
| 2 | Industrials | 16.16% |
| 3 | Communication Services | 12.51% |
| 4 | Consumer Discretionary | 11.49% |
| 5 | Materials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
76
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – |
-93,000
| Closed | -$1.59M |
|
77
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-8,000
| Closed | -$723K |
|
78
Bristol-Myers Squibb
BMY
$96B
| – | – |
0
| – | – |
|
79
Cooper Companies
COO
$13.4B
| – | – |
-3,000
| Closed | -$486K |
|
80
eHealth
EHTH
$118M
| – | – |
-65,500
| Closed | -$1.63M |
|
81
GameStop
GME
$10B
| – | – |
0
| – | – |
|
|
KATE
82
DELISTED
Kate Spade & Company
KATE
| – | – |
-22,000
| Closed | -$704K |
|
|
HNT
83
DELISTED
HEALTH NET INC
HNT
| – | – |
-27,900
| Closed | -$1.49M |
|
|
GMCR
84
DELISTED
KEURIG GREEN MTN INC
GMCR
| – | – |
-6,000
| Closed | -$794K |
|
|
SLXP
85
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| – | – |
-2,500
| Closed | -$287K |
|
|
AVNR
86
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| – | – |
-128,674
| Closed | -$2.18M |
|
|
AGN
87
DELISTED
ALLERGAN INC
AGN
| – | – |
-11,300
| Closed | -$2.4M |
|